Discovery analysis
Tooling

Unlock the full potential of your discovery research with our platform’s intuitive user interface, designed for scientists of all backgrounds. Whether you’re working with NGS, Sanger, single B cells, or multiple technologies, our platform integrates all sequence and assay data seamlessly.

Empower your discovery with intuitive,
cutting-edge software

Easily perform analyses like clustering, phylogeny, and exposed liability predictions —all without the need for coding. With powerful, user-friendly analysis tools, you can transform data into actionable insights, making it easier than ever to identify and prioritize top candidates.

Effortlessly integrate ML models created by your team or third parties, keeping your therapeutic development at the forefront of technological advancements. Leverage your biological expertise to explore and engage with data directly, while our platform manages the technical complexities.

Interactive. Scalable. Feature-rich.

All discovery approaches
analyzed in a single environment

Cloud-IGX-Platform-for-antibody-discovery

These functionalities allow the platform to adapt to your discovery approach. Whether you are focusing on hit selection, hit expansion, or enrichment analysis, this intuitive environment supports both in vitro and in vivo generation and screening, providing a straightforward path to the best leads. Enjoy a unified, adaptable environment that supports and evolves with your discovery workflows.

Rationally select the best therapeutic candidates

De-risk your candidate selection with our innovative developability assessment. Leveraging advanced machine learning, our platform rapidly generates accurate 3D models that focus on exposed sequence liabilities and developabilities. This innovative approach enhances predictive accuracy without requiring any expertise, easily integrating into your existing workflows. Improve your discovery process by making informed decisions that minimize engineering and optimization efforts, ensuring a smoother path to developing the most promising therapeutic candidates.

Data-driven candidate selection with rich visualizations

Lead selection involves evaluating an array of characteristics and molecular properties, and our platform empowers you to do this with ease. Associate any assay or experimental data, including in-silico predictions, directly with your clones and overlay them through information-rich visualizations. Streamline your workflow towards functionality-first selection, ensuring every candidate is assessed with all relevant information at your fingertips. Leave guesswork behind—embrace data-driven discovery, backed by actionable insights, and aligned with your ultimate therapeutic goals.

Revolutionize your discovery with AI-driven insights

Biologics discovery and engineering are being transformed by ML models that predict diverse properties, identify potential issues, and suggest optimizations. Our platform enables seamless integration of the latest AI tools —whether developed internally or externally— into your discovery process, empowering you to enhance candidate selection and engineering with cutting-edge algorithms. We eliminate technological barriers and allow you to incorporate ML models early on, so you can improve your discovery campaigns and push the boundaries of innovation. Let AI-driven innovation pave the way to groundbreaking therapeutics.

Leaders in scientific research choose ENPICOM

Transform your research with seamless data integration and future-ready data science

Contact us for a personalized demo today.

Top